Navigation Links
Boston Scientific Statement on the Passing of Senator Edward Kennedy
Date:8/26/2009

NATICK, Mass., Aug. 26 /PRNewswire/ --

The statement below is from Pete Nicholas, Chairman of the Board of Boston Scientific Corporation, on behalf of the Company, its employees and its Board of Directors.

Senator Kennedy leaves a legacy of unprecedented accomplishment across a remarkably broad spectrum of issues. Foremost among them was his long and productive work on health care, a cause we shared with him.

He was a tireless advocate for patients' rights and for access to quality health care for all. Over the past half century, he was involved in the passage of virtually every piece of major health care legislation, from Medicare in the 1960s to the recent children's health insurance bill.

We were fortunate to have Senator Kennedy visit our facilities to learn about our products and technologies and to thank our employees for all they do to improve patients' lives.

We are profoundly grateful for the opportunity to have known him, to have worked with him and to have been inspired by him.

Our tribute - and pledge - to Senator Kennedy is to continue working relentlessly on behalf of patients, many of whom saw him as their most dedicated champion and for whom medical innovation offers the greatest hope for restored health.

We will miss Senator Kennedy very much.

We extend our deepest sympathies to his family.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

    CONTACT: Paul Donovan
             508-650-8541 (office)
             508-667-5165 (mobile)
             Media Relations
             Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Boston Scientific to Webcast Conference Call Discussing Results of Landmark MADIT-CRT Trial
2. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
3. Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
4. Boston Scientific to Participate in Wachovia Conference
5. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
6. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
7. FDA Approves Boston Scientifics Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
8. Angiotechs corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
9. Boston Scientific Welcomes Launch of Syntax Score Website
10. Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Childrens Hospital Boston and Massachusetts General Hospital
11. Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... -- The Texas Medical Center (TMC) and the ... announced the establishment of a new international BioBridge, a ... and the Texas Medical Center, the largest ... and the Texas Medical Center, with the support of ... health innovation ecosystem where emerging technologies can be developed, ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... both cellulose nanocrystals and cellulose nanofibrils. The composition claims are not limited ... also claims directed to combination with polymers, carbon fibers, graphene, and other materials. ...
(Date:12/5/2016)... December 5, 2016 According ... Market, by Products (Consumable, Instruments, Automated Cell Expansion ... and Stem Cell Research, Cancer, and Cell-Based Research), ... Banks) - Global Revenue, Trends, Growth, Share, Size ... Research, the global cell expansion market is expected ...
(Date:12/5/2016)... , Dec. 5, 2016  Eisai Inc. ... open-label two-year study of rufinamide, which were presented ... Epilepsy Society (AES) held from December 2-6 in ... final two-year safety, tolerability and cognitive data showed ... experienced similar safety and tolerability profiles, cognitive development ...
Breaking Biology Technology:
(Date:11/17/2016)... Nov. 17, 2016  AIC announces that it has just released a new white ... require high-performance scale-out plus high speed data transfer storage solutions. Photo - ... ... ... Setting up a high performance computing or ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
Breaking Biology News(10 mins):